These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 30957568)
1. Effects of kisspeptin on pathogenesis and energy metabolism in polycystic ovarian syndrome (PCOS). Wang T; Han S; Tian W; Zhao M; Zhang H Gynecol Endocrinol; 2019 Sep; 35(9):807-810. PubMed ID: 30957568 [TBL] [Abstract][Full Text] [Related]
2. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276 [TBL] [Abstract][Full Text] [Related]
3. Is there a role for kisspeptin in pathogenesis of polycystic ovary syndrome? Gorkem U; Togrul C; Arslan E; Sargin Oruc A; Buyukkayaci Duman N Gynecol Endocrinol; 2018 Feb; 34(2):157-160. PubMed ID: 28933574 [TBL] [Abstract][Full Text] [Related]
4. Correlation between kisspeptin and biochemical markers in obese and non-obese women with polycystic ovary syndrome. Gao M; Tao X; Zhang Q; He W; Zhao T; Yuan T Gynecol Endocrinol; 2023 Dec; 39(1):2215869. PubMed ID: 37236245 [No Abstract] [Full Text] [Related]
5. rs4889 polymorphism in KISS1 gene, its effect on polycystic ovary syndrome development and anthropometric and hormonal parameters in Saudi women. Albalawi FS; Daghestani MH; Daghestani MH; Eldali A; Warsy AS J Biomed Sci; 2018 May; 25(1):50. PubMed ID: 29848339 [TBL] [Abstract][Full Text] [Related]
6. Serum kisspeptin levels correlated with anti-mullerian hormone levels in women with and without polycystic ovarian syndrome. Mut A; Erel CT; İnan D; Öner YÖ Gynecol Endocrinol; 2021 May; 37(5):462-466. PubMed ID: 32964765 [TBL] [Abstract][Full Text] [Related]
7. Role of kisspeptin in polycystic ovary syndrome (PCOS). Emekci Ozay O; Ozay AC; Acar B; Cagliyan E; Seçil M; Küme T Gynecol Endocrinol; 2016 Sep; 32(9):718-722. PubMed ID: 27003383 [TBL] [Abstract][Full Text] [Related]
8. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
9. Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome. Jeon YE; Lee KE; Jung JA; Yim SY; Kim H; Seo SK; Cho S; Choi YS; Lee BS Gynecol Obstet Invest; 2013; 75(4):268-74. PubMed ID: 23571154 [TBL] [Abstract][Full Text] [Related]
10. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Li X; Lin JF Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817 [TBL] [Abstract][Full Text] [Related]
11. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome. Orio F; Palomba S; Colao A; Russo T; Dentico C; Tauchmanovà L; Savastano S; Nappi C; Sultan C; Zullo F; Lombardi G J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737 [TBL] [Abstract][Full Text] [Related]
12. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome]. Li Y; Wei LN; Xiong YL; Liang XY Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609 [TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome. Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552 [TBL] [Abstract][Full Text] [Related]
14. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Dale PO; Tanbo T; Vaaler S; Abyholm T Fertil Steril; 1992 Sep; 58(3):487-91. PubMed ID: 1521640 [TBL] [Abstract][Full Text] [Related]
15. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome]. Ságodi L; Lombay B; Vámosi I; Barkai L Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991 [TBL] [Abstract][Full Text] [Related]
16. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364 [TBL] [Abstract][Full Text] [Related]
17. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615 [TBL] [Abstract][Full Text] [Related]
18. Alteration of ghrelin/obestatin ratio in adolescence with polycystic ovarian syndrome. Wu W; Fan X; Yu Y; Wang Z; Wang Y Gynecol Endocrinol; 2018 Jan; 34(1):36-39. PubMed ID: 28649890 [TBL] [Abstract][Full Text] [Related]
19. Kisspeptin and body weight homeostasis in relation to phenotypic features of polycystic ovary syndrome; metabolic regulation of reproduction. Rashad NM; Al-Sayed RM; Yousef MS; Saraya YS Diabetes Metab Syndr; 2019; 13(3):2086-2092. PubMed ID: 31235141 [TBL] [Abstract][Full Text] [Related]